# Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer

> **NCT04868045** · PHASE1 · WITHDRAWN · sponsor: **Memorial Sloan Kettering Cancer Center**

## Conditions studied

- Thyroid Cancer

## Interventions

- **DRUG:** Thyrotropin Releasing Hormone (TRH)
- **DRUG:** levothyroxine
- **OTHER:** Hypothyroidism QOL questionnaire

## Key facts

- **NCT ID:** NCT04868045
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-04-27
- **Primary completion:** 2023-02-15
- **Final completion:** 2023-02-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of accrual
- **Last updated:** 2023-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04868045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04868045, "Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04868045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*